These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased gut glucagon release as pathogenetic factor in reactive hypoglycaemia? Rehfeld JF; Heding LG; Holst JJ Lancet; 1973 Jan; 1(7795):116-8. PubMed ID: 4118464 [No Abstract] [Full Text] [Related]
3. An enteroglucagon tumour. Bloom SR Gut; 1972 Jul; 13(7):520-3. PubMed ID: 5069726 [TBL] [Abstract][Full Text] [Related]
4. Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function. Gleeson MH; Bloom SR; Polak JM; Henry K; Dowling RH Gut; 1971 Oct; 12(10):773-82. PubMed ID: 4941684 [TBL] [Abstract][Full Text] [Related]
5. Gut glucagon and reactive hypoglycaemia. Bloom S Lancet; 1973 Jan; 1(7796):202. PubMed ID: 4118814 [No Abstract] [Full Text] [Related]
6. Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with their membrane receptors. Bataille D; Rosselin G; Freychet P Isr J Med Sci; 1975 Jul; 11(7):687-92. PubMed ID: 169214 [No Abstract] [Full Text] [Related]
7. Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase. Bataille D; Freychet P; Rosselin G Endocrinology; 1974 Sep; 95(3):713-21. PubMed ID: 4368831 [No Abstract] [Full Text] [Related]
8. Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. Murray-Lyon IM; Eddleston AL; Williams R; Brown M; Hogbin BM; Bennett A; Edwards JC; Taylor KW Lancet; 1968 Oct; 2(7574):895-8. PubMed ID: 4176152 [No Abstract] [Full Text] [Related]
11. Molecular weight of gut and pancreatic circulating glucagon in the duck. Krug E; Biehler O; Mialhe P Horm Metab Res; 1971 Jul; 3(4):258-61. PubMed ID: 5129985 [No Abstract] [Full Text] [Related]
13. [Tumoral hypoglycemia and its treatment]. Debry G Rev Med Liege; 1974 Apr; 29(8):233-5. PubMed ID: 4596927 [No Abstract] [Full Text] [Related]
14. Hormone-producing tumours of the pancreas. Giddings AE Practitioner; 1975 Jun; 214(1284):795-800. PubMed ID: 167363 [No Abstract] [Full Text] [Related]
15. [Insulin and glucagon receptors in the liver. Their regulation]. Broer Y Med Chir Dig; 1981; 10(8):669-71. PubMed ID: 6279980 [No Abstract] [Full Text] [Related]
16. Glucagon responses to exercise-induced hypoglycaemia are improved by somatostatin receptor type 2 antagonism in a rat model of diabetes. Leclair E; Liggins RT; Peckett AJ; Teich T; Coy DH; Vranic M; Riddell MC Diabetologia; 2016 Aug; 59(8):1724-31. PubMed ID: 27075449 [TBL] [Abstract][Full Text] [Related]
17. Hypoglycemia associated with extrapancreatic tumors. An immunofluorescent study. Saeed SM; Fine G; Horn RC Cancer; 1969 Jul; 24(1):158-66. PubMed ID: 4307126 [No Abstract] [Full Text] [Related]
18. Can somatostatin antagonism prevent hypoglycaemia during exercise in type 1 diabetes? Taleb N; Rabasa-Lhoret R Diabetologia; 2016 Aug; 59(8):1632-5. PubMed ID: 27153841 [TBL] [Abstract][Full Text] [Related]
19. Cephalic phase secretion of insulin and other enteropancreatic hormones in humans. Veedfald S; Plamboeck A; Deacon CF; Hartmann B; Knop FK; Vilsbøll T; Holst JJ Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G43-51. PubMed ID: 26492921 [TBL] [Abstract][Full Text] [Related]
20. Untractable hypoglycemia in an infant: studies on pancreas insulin and glucagon. Rancon F; Laburthe M; Rosselin G; Freychet P Horm Metab Res; 1974 Nov; 6(6):443-7. PubMed ID: 4452544 [No Abstract] [Full Text] [Related] [Next] [New Search]